• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单羧酸转运体在药物脑内递送中的作用。

Role of monocarboxylate transporters in drug delivery to the brain.

作者信息

Vijay Nisha, Morris Marilyn E

机构信息

University at Buffalo, 352 Kapoor Hall, Buffalo, NY 14214-8033.

出版信息

Curr Pharm Des. 2014;20(10):1487-98. doi: 10.2174/13816128113199990462.

DOI:10.2174/13816128113199990462
PMID:23789956
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4084603/
Abstract

Monocarboxylate transporters (MCTs) are known to mediate the transport of short chain monocarboxylates such as lactate, pyruvate and butyrate. Currently, fourteen members of this transporter family have been identified by sequence homology, of which only the first four members (MCT1- MCT4) have been shown to mediate the proton-linked transport of monocarboxylates. Another transporter family involved in the transport of endogenous monocarboxylates is the sodium coupled MCTs (SMCTs). These act as a symporter and are dependent on a sodium gradient for their functional activity. MCT1 is the predominant transporter among the MCT isoforms and is present in almost all tissues including kidney, intestine, liver, heart, skeletal muscle and brain. The various isoforms differ in terms of their substrate specificity and tissue localization. Due to the expression of these transporters in the kidney, intestine, and brain, they may play an important role in influencing drug disposition. Apart from endogenous short chain monocarboxylates, they also mediate the transport of exogenous drugs such as salicylic acid, valproic acid, and simvastatin acid. The influence of MCTs on drug pharmacokinetics has been extensively studied for γ-hydroxybutyrate (GHB) including distribution of this drug of abuse into the brain and the results will be summarized in this review. The physiological role of these transporters in the brain and their specific cellular localization within the brain will also be discussed. This review will also focus on utilization of MCTs as potential targets for drug delivery into the brain including their role in the treatment of malignant brain tumors.

摘要

已知单羧酸转运体(MCTs)介导乳酸、丙酮酸和丁酸等短链单羧酸的转运。目前,通过序列同源性已鉴定出该转运体家族的14个成员,其中只有前四个成员(MCT1 - MCT4)被证明介导单羧酸的质子偶联转运。另一个参与内源性单羧酸转运的转运体家族是钠偶联MCTs(SMCTs)。这些转运体作为同向转运体,其功能活性依赖于钠梯度。MCT1是MCT同工型中的主要转运体,几乎存在于所有组织中,包括肾脏、肠道、肝脏、心脏、骨骼肌和大脑。各种同工型在底物特异性和组织定位方面存在差异。由于这些转运体在肾脏、肠道和大脑中的表达,它们可能在影响药物处置方面发挥重要作用。除了内源性短链单羧酸外,它们还介导水杨酸、丙戊酸和辛伐他汀酸等外源性药物的转运。MCTs对药物药代动力学的影响已针对γ-羟基丁酸(GHB)进行了广泛研究,包括这种滥用药物在大脑中的分布情况,相关结果将在本综述中进行总结。还将讨论这些转运体在大脑中的生理作用及其在大脑中的特定细胞定位。本综述还将重点关注利用MCTs作为将药物递送至大脑的潜在靶点,包括它们在治疗恶性脑肿瘤中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bb2/4084603/5b963e685975/nihms589885f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bb2/4084603/e20cbddb5b23/nihms589885f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bb2/4084603/58cc017deff6/nihms589885f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bb2/4084603/553e651816e8/nihms589885f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bb2/4084603/5b963e685975/nihms589885f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bb2/4084603/e20cbddb5b23/nihms589885f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bb2/4084603/58cc017deff6/nihms589885f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bb2/4084603/553e651816e8/nihms589885f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bb2/4084603/5b963e685975/nihms589885f4.jpg

相似文献

1
Role of monocarboxylate transporters in drug delivery to the brain.单羧酸转运体在药物脑内递送中的作用。
Curr Pharm Des. 2014;20(10):1487-98. doi: 10.2174/13816128113199990462.
2
Overview of the proton-coupled MCT (SLC16A) family of transporters: characterization, function and role in the transport of the drug of abuse gamma-hydroxybutyric acid.质子偶联单羧酸转运体(SLC16A)家族转运蛋白概述:特性、功能及在滥用药物γ-羟基丁酸转运中的作用
AAPS J. 2008 Jun;10(2):311-21. doi: 10.1208/s12248-008-9035-6. Epub 2008 Jun 4.
3
Molecular features, regulation, and function of monocarboxylate transporters: implications for drug delivery.单羧酸转运体的分子特征、调控及功能:对药物递送的影响
J Pharm Sci. 2003 Aug;92(8):1531-44. doi: 10.1002/jps.10389.
4
The drug of abuse gamma-hydroxybutyrate is a substrate for sodium-coupled monocarboxylate transporter (SMCT) 1 (SLC5A8): characterization of SMCT-mediated uptake and inhibition.滥用药物γ-羟基丁酸是钠偶联单羧酸转运体(SMCT)1(SLC5A8)的一种底物:SMCT介导的摄取和抑制特性
Drug Metab Dispos. 2009 Jul;37(7):1404-10. doi: 10.1124/dmd.109.027169. Epub 2009 Apr 23.
5
Monocarboxylic acid transport.一元羧酸转运。
Compr Physiol. 2013 Oct;3(4):1611-43. doi: 10.1002/cphy.c130008.
6
Cellular distributions of monocarboxylate transporters: a review.单羧酸转运蛋白的细胞分布:综述
Biomed Res. 2015;36(5):279-301. doi: 10.2220/biomedres.36.279.
7
Monocarboxylate Transporters (SLC16): Function, Regulation, and Role in Health and Disease.单羧酸转运蛋白(SLC16):功能、调节及其在健康和疾病中的作用。
Pharmacol Rev. 2020 Apr;72(2):466-485. doi: 10.1124/pr.119.018762.
8
Distribution of monocarboxylate transporters MCT1-MCT8 in rat tissues and human skeletal muscle.单羧酸转运蛋白MCT1 - MCT8在大鼠组织和人类骨骼肌中的分布。
Appl Physiol Nutr Metab. 2006 Feb;31(1):31-9. doi: 10.1139/h05-002.
9
Monocarboxylate transporters in the central nervous system: distribution, regulation and function.中枢神经系统中的单羧酸转运体:分布、调节与功能
J Neurochem. 2005 Jul;94(1):1-14. doi: 10.1111/j.1471-4159.2005.03168.x.
10
Tissue-specific expression of monocarboxylate transporters during fasting in mice.小鼠禁食期间单羧酸转运蛋白的组织特异性表达。
PLoS One. 2014 Nov 12;9(11):e112118. doi: 10.1371/journal.pone.0112118. eCollection 2014.

引用本文的文献

1
Potential impacts of acupuncture on motor function recovery after ischemic stroke: insights from basic and clinical studies.针刺对缺血性中风后运动功能恢复的潜在影响:来自基础与临床研究的见解
Front Cell Neurosci. 2025 Aug 13;19:1623535. doi: 10.3389/fncel.2025.1623535. eCollection 2025.
2
Neurophysiological Basis of Short-Chain Fatty Acid Action in Pain Modulation: Therapeutic Implications.短链脂肪酸在疼痛调节中的作用的神经生理学基础:治疗意义
Int J Mol Sci. 2025 Aug 21;26(16):8082. doi: 10.3390/ijms26168082.
3
Nanoparticle‑based delivery systems for targeted therapy in brain tumors: Progress, challenges and perspectives (Review).

本文引用的文献

1
Significance of short chain fatty acid transport by members of the monocarboxylate transporter family (MCT).单羧酸转运蛋白家族(MCT)成员转运短链脂肪酸的意义。
Neurochem Res. 2012 Nov;37(11):2562-8. doi: 10.1007/s11064-012-0857-3. Epub 2012 Aug 10.
2
MCT8 deficiency: extrapyramidal symptoms and delayed myelination as prominent features.MCT8缺乏症:锥体外系症状和髓鞘形成延迟为突出特征。
J Child Neurol. 2013 Jun;28(6):795-800. doi: 10.1177/0883073812450944. Epub 2012 Jul 17.
3
Alterations of monocarboxylate transporter densities during hypoxia in brain and breast tumour cells.
基于纳米颗粒的脑肿瘤靶向治疗递送系统:进展、挑战与展望(综述)
Int J Oncol. 2025 Oct;67(4). doi: 10.3892/ijo.2025.5789. Epub 2025 Aug 24.
4
Beyond the gut: decoding the gut-immune-brain axis in health and disease.超越肠道:解读健康与疾病中的肠道-免疫-脑轴
Cell Mol Immunol. 2025 Aug 14. doi: 10.1038/s41423-025-01333-3.
5
Brain Tumor-Induced Changes in Routine Parameters of the Lipid Spectrum of Blood Plasma and Its Short-Chain Fatty Acids.脑肿瘤引起的血浆脂质谱及其短链脂肪酸常规参数的变化。
Curr Issues Mol Biol. 2025 Mar 26;47(4):228. doi: 10.3390/cimb47040228.
6
Dimethyl-2-oxoglutarate but not antioxidants prevents glucose hypometabolism induced neural cell death: implications in the pathogenesis and therapy of Alzheimer's disease.2-氧代戊二酸二甲酯而非抗氧化剂可预防葡萄糖代谢减退诱导的神经细胞死亡:对阿尔茨海默病发病机制及治疗的启示
Biochem Biophys Rep. 2025 Jul 12;43:102150. doi: 10.1016/j.bbrep.2025.102150. eCollection 2025 Sep.
7
Blood‑brain barrier dysfunction in epilepsy: Mechanisms, therapeutic strategies and future orientation (Review).癫痫中的血脑屏障功能障碍:机制、治疗策略及未来方向(综述)
Int J Mol Med. 2025 Sep;56(3). doi: 10.3892/ijmm.2025.5577. Epub 2025 Jul 4.
8
Crossing the Blood-Brain Barrier: Innovations in Receptor- and Transporter-Mediated Transcytosis Strategies.穿越血脑屏障:受体介导和转运体介导的转胞吞作用策略的创新
Pharmaceutics. 2025 May 28;17(6):706. doi: 10.3390/pharmaceutics17060706.
9
Tea and Its Active Ingredients in Preventing and Alleviating Depression: A Comprehensive Review.茶及其活性成分在预防和缓解抑郁症中的作用:综述
Foods. 2025 Jun 11;14(12):2054. doi: 10.3390/foods14122054.
10
The emerging role of microbiota derived SCFAs in neurodegenerative disorders.微生物群衍生的短链脂肪酸在神经退行性疾病中的新作用。
Brain Behav Immun Health. 2025 May 7;46:101012. doi: 10.1016/j.bbih.2025.101012. eCollection 2025 Jul.
缺氧时脑和乳腺癌细胞中单羧酸转运蛋白密度的改变。
Cell Oncol (Dordr). 2012 Jun;35(3):217-27. doi: 10.1007/s13402-012-0081-9. Epub 2012 Jun 15.
4
[Expression of monocarboxylate transporter 8 mRNA in the brain tissue of rats with cerebral ischemia].[单羧酸转运体8 mRNA在脑缺血大鼠脑组织中的表达]
Nan Fang Yi Ke Da Xue Xue Bao. 2012 Jun;32(6):913-5.
5
Role of monocarboxylate transporters in human cancers: state of the art.单羧酸转运蛋白在人类癌症中的作用:最新进展。
J Bioenerg Biomembr. 2012 Feb;44(1):127-39. doi: 10.1007/s10863-012-9428-1.
6
The monocarboxylate transporter family--Structure and functional characterization.单羧酸转运蛋白家族——结构与功能特征。
IUBMB Life. 2012 Jan;64(1):1-9. doi: 10.1002/iub.573. Epub 2011 Nov 30.
7
Tyrosine kinase inhibitors noncompetitively inhibit MCT8-mediated iodothyronine transport.酪氨酸激酶抑制剂非竞争性抑制 MCT8 介导的甲状腺素转运。
J Clin Endocrinol Metab. 2012 Jan;97(1):E100-5. doi: 10.1210/jc.2011-1837. Epub 2011 Oct 26.
8
Brain uptake of the drug of abuse γ-hydroxybutyric acid in rats.大鼠滥用药物 γ-羟基丁酸的脑摄取。
Drug Metab Dispos. 2012 Jan;40(1):212-8. doi: 10.1124/dmd.111.041749. Epub 2011 Oct 21.
9
γ-Hydroxybutyrate blood/plasma partitioning: effect of physiologic pH on transport by monocarboxylate transporters.γ-羟基丁酸血/血浆分配:生理 pH 对单羧酸转运蛋白转运的影响。
Drug Metab Dispos. 2012 Jan;40(1):64-9. doi: 10.1124/dmd.111.041285. Epub 2011 Oct 5.
10
Monocarboxylate transporter 2 and stroke severity in a rodent model of sleep apnea.单羧酸转运蛋白 2 与睡眠呼吸暂停啮齿动物模型中中风严重程度的关系。
J Neurosci. 2011 Jul 13;31(28):10241-8. doi: 10.1523/JNEUROSCI.1462-11.2011.